8-K STELLA PHASE 2

Company

NovoCure Ltd

Filed

September 6, 2018

Period of Report

September 5, 2018

Accession Number

0001564590-18-022699

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →